@article{4d93fea41dca40fbb8632d05c6e66e6c,
title = "Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries",
abstract = "To assess the 6-month effectiveness of the first rituximab (RTX) course in rheumatoid arthritis (RA) and to identify possible predictors of response.",
keywords = "Adult, Aged, Antibodies, Monoclonal, Murine-Derived, Antirheumatic Agents, Arthritis, Rheumatoid, Autoantibodies, Biological Markers, Drug Evaluation, Epidemiologic Methods, Female, Humans, Male, Middle Aged, Peptides, Cyclic, Prognosis, Rheumatoid Factor, Treatment Failure, Treatment Outcome, Tumor Necrosis Factor-alpha",
author = "Katerina Chatzidionysiou and Elisabeth Lie and Evgeny Nasonov and Galina Lukina and Hetland, {Merete Lund} and Ulrik Tarp and Cem Gabay and {van Riel}, {Piet L C M} and Nordstr{\"o}m, {Dan C} and Juan Gomez-Reino and Karel Pavelka and Matija Tomsic and Kvien, {Tore K} and {van Vollenhoven}, {Ronald F}",
year = "2011",
doi = "10.1136/ard.2010.148759",
language = "English",
volume = "70",
pages = "1575--1580",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "Elsevier BV",
number = "9",
}